Key Points About the US FDA’s Probe into Indian Spice (MDH) Contamination

Recently, the US Food and Drug Administration (FDA) launched an investigation into allegations of cancer-causing pesticide contamination in Indian spice blends. Here are five key points to understand the situation:

1. Controversy Over Spice Mixes: The FDA is looking into the composition of spice blends from two Indian spice makers amid concerns of high levels of cancer-causing pesticides. Hong Kong recently banned three MDH spice mixes and one Everest blend due to alleged hazardous amounts of ethylene oxide.
2. FDA’s Response: The FDA is actively reviewing the reports and is gathering more information about the alleged contamination. The agency is taking the issue seriously to ensure the safety of consumers.
3. Brands’ Responses: Everest has stated that its spices are safe for consumption and are exported only after receiving necessary clearances and approval from the Spice Board of India’s laboratories. On the other hand, MDH has dismissed the allegations as baseless and lacking substantiating evidence.
4. Spices Board’s Involvement: The Spices Board of India is working with authorities in Hong Kong and Singapore to get more information about the alleged contamination. The Board is also conducting inspections at the plants to ensure adherence to regulatory standards.
5. Past Controversies: This is not the first time Indian spice brands have faced controversy. In 2019, MDH’s sambhar powder was recalled in northern California due to salmonella contamination. FDA had warned against consuming the product as salmonella can cause foodborne illnesses.

In conclusion, the FDA’s probe into the alleged contamination of Indian spice blends highlights the importance of food safety and regulatory standards. Consumers should stay informed and cautious about the products they consume to avoid potential health risks.
For more information, visit our homepage
Follow us on Facebook and Instagram